Brief: Vanda Pharmaceuticals Q2 EPS USD -1.04
05/08/2026 21:02
BRIEF-Vanda Pharmaceuticals Q2 EPS USD -1.04 Aug 05 (Reuters) - Vanda Pharmaceuticals Q2 net income USD -62.513 million.
- Q2 basic EPS USD -1.04
- Q2 operating expenses USD 114.338 million
- Q2 operating income USD -63.809 million
Recent news on Vanda Pharmaceuticals
See all newsUS STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending Spoons
US STOCKS ON THE MOVE-Walmart, Super Micro, FMC
US STOCKS ON THE MOVE-Nvidia, Penske Automotive, ManpowerGroup
US STOCKS ON THE MOVE-Barrick Mining, Venture Global, GE Vernova
Vanda Pharma shares slip as trial failure halts anxiety drug program